Phosphatidylserines: Clinical Trials

13 trials of Phosphatidylserines, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 2 unknown, 1 recruiting, 1 terminated. 12 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable12Completed 8, Unknown 2, Recruiting 1, Terminated 1
Phase 21Completed 1

Follow Phosphatidylserines: new trials by email Literature Review of Phosphatidylserines trials Research Report on Phosphatidylserines

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TCP-600 Supplementation and Performance Response in Professional Football Players
Placebo, Taurine, Caffeine - Athletic Performance, Cognitive Fatigue
Not applicableRecruitingVizja University in Warsaw652026-09-012026-09-08
Phosphatidylserine, Taurine, and Caffeine for Cognitive Fatigue in Professional Football Players
Placebo, Taurine Plus Caffeine, Taurine, Caffeine, and Phosphatidylserine - Mental Fatigue, Cognitive Performance
Not applicableCompletedVizja University in Warsaw652026-08-062026-09-14
Multi-Ingredient Supplementation in Professional Football Players
Placebo, taurine, Caffeine - Sports Performance, Cognitive Performance During Physical Activity
Not applicableCompletedVizja University in Warsaw972026-06-142026-07-02
Effects of Supplementation on Performance in Football Players
Placebo, Taurine and Caffeine, Taurine, Caffeine, and Phosphatidylserine - Physical Performance, Cognitive Performance
Not applicableCompletedKrzysztof Mizera812025-03-252026-05-26
Effects of Phosphatidylserine and DHA on Cognitive Performance in Children With ADHD
Placebo, Phosphatidylserine-Omega3, DHA Omega-3 - Attention Deficit Hyperactivity Disorder (ADHD), ADHD
Not applicableCompletedÇağlar Charles Daniel Jaicks452023-12-302026-04-13
ADAM17 and Vascular Function in Diabetes
Placebo, Phosphatidylserine - Diabetes Mellitus, Type 2
Not applicableCompletedUniversity of Missouri-Columbia362023-03-012026-05-04
Phosphatidylserine Improves Cognitive Function in the Elderly
Phosphatidylserine, Bean powder - Aging
Not applicableUnknownFirst Affiliated Hospital Xi'an Jiaotong University1002022-09-012022-05-11
The Effect of Phosphatidylserine on Time Trial Performance in Trained Male Cyclists
Phosphatidylserine - The Focus of the Study is to Investigate the Effects of Phosphatidylserine Supplementation on Exercise Physiology and Cycling Time-trial Performance
Not applicableUnknownMark Glaister202021-07-152021-07-19
Dose-Response Effect of Phosphatidylserine on eSport Performance
Placebo, Phosphatidylserine (100 mg), Phosphatidylserine (200 mg) - Cognitive Function, Gaming Performance
Not applicableCompletedLindenwood University802021-06-152026-04-16
The Cognitive Effects of 6- and 12-weeks Administration of a Food Supplement Containing Phosphatidylserine in Healthy Children Aged 8 to 12 Years
Phosphatidylserine, Placebo - Cognitive Change
Not applicableCompletedNorthumbria University2082020-11-022022-09-28
Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment
Phosphatidylserine, Placebo - Mild Cognitive Impairment
Not applicableTerminatedEnzymotec972014-09-012018-02-05
The Nutritional Supplement Phosphatidylserine in Patients With Familial Dysautonomia
Phosphatidylserine - Familial Dysautonomia
Phase 2CompletedNYU Langone Health262011-11-012021-02-21
Single Photon Emission Computed Tomography (SPECT) Imaging Study of Professional American Football Players
Multivitamin Supplement intervention - Traumatic Brain Injury
Not applicableCompletedAmen Clinics, Inc.1002009-05-012012-01-24

Conditions studied

Mental Fatigue (2)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Brain Injuries, Traumatic (1)  ·  Cognitive Dysfunction (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Dysautonomia, Familial (1)  ·  Fatigue (1)

Sponsors

Vizja University in Warsaw (3)  ·  Amen Clinics, Inc. (1)  ·  Enzymotec (1)  ·  First Affiliated Hospital Xi'an Jiaotong University (1)  ·  Krzysztof Mizera (1)  ·  Lindenwood University (1)  ·  Mark Glaister (1)  ·  NYU Langone Health (1)  ·  Northumbria University (1)  ·  University of Missouri-Columbia (1)  ·  Çağlar Charles Daniel Jaicks (1)

Countries

United States (5)  ·  Poland (4)  ·  China (1)  ·  Hungary (1)  ·  Israel (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Chad M Kerksick, PhD (1)  ·  Daniel G Amen, MD (1)  ·  Horacio Kaufmann, MD (1)  ·  Philippa Jackson (1)  ·  Weimin Li, Dr. (1)  ·  Yehudit Aharon, MD (1)

Results publications

PMID 21304145, PMID 21615001, PMID 41318468